Skip to main content

Advertisement

Log in

Psychiatric, Behavioural and Social Risk Factors for HIV Infection Among Female Drug Users

  • Original Paper
  • Published:
AIDS and Behavior Aims and scope Submit manuscript

Abstract

Female drug users report greater psychopathology and risk behaviours than male drug users, putting them at greater risk for HIV. This mixed-methods study determined psychiatric, behavioural and social risk factors for HIV among 118 female drug users (27% (32/118) were HIV seropositive) in Barcelona. DSM-IV disorders were assessed using the Spanish Psychiatric Research Interview for Substance and Mental Disorders. 30 participants were interviewed in-depth. In stepwise multiple backward logistic regression, ever injected with a used syringe, antisocial personality disorder, had an HIV seropositive sexual partner and substance-induced major depressive disorder were associated with HIV seropositivity. Qualitative findings illustrate the complex ways in which psychiatric disorders and male drug-using partners interact with these risk factors. Interventions should address all aspects of female drug users’ lives to reduce HIV.

Resumen

Las mujeres consumidoras de drogas presentan más psicopatología y conductas de riesgo que los consumidores, exponiéndolas a un riesgo mayor de contraer la infección por el VIH. El objetivo del presente estudio fue evaluar, mediante metodología mixta, los factores de riesgo psiquiátricos, comportamentales y sociales para la infección por el VIH en 118 mujeres consumidoras de drogas (27% (32/118) seropositivas para el VIH) en Barcelona. Los trastornos psiquiátricos (según criterios DSM-IV) se evaluaron mediante la versión española de la Psychiatric Research Interview for Substance and Mental Disorders. Se entrevistaron a 30 mujeres en profundidad. En la regresión logística, los factores que se asociaron a la infección por el VIH fueron la inyección con jeringuillas usadas previamente, tener el trastorno de personalidad antisocial, una pareja sexual con infección por el VIH y tener una depresión mayor inducida por sustancias. Los análisis cualitativos ilustraron la complejidad con que los trastornos psiquiátricos y las parejas consumidoras interactúan con estos factores de riesgo. Las intervenciones diseñadas para reducir la infección del VIH deberían abordar diferentes aspectos de la vida de las mujeres usuarias de drogas.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Mathers BM, Degenhardt L, Phillips B, et al. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet. 2008;15:1733–45.

    Article  Google Scholar 

  2. Strathdee SA, Galai N, Safaiean M, et al. Sex differences in risk factors for hiv seroconversion among injection drug users: a 10-year perspective. Arch Intern Med. 2001;161:1281–8.

    Article  PubMed  CAS  Google Scholar 

  3. Dwyer R, Richardson D, Ross MW, Wodak A, Miller ME, Gold JA. Comparison of HIV risk between women and men who inject drugs. AIDS Educ Prev. 1994;6:379–89.

    PubMed  CAS  Google Scholar 

  4. El-Bassel N, Simoni JM, Cooper DK, Gilbert L, Schilling RF. Sex trading and psychological distress among women on methadone. Psychol Addict Behav. 2001;15:177–84.

    Article  PubMed  CAS  Google Scholar 

  5. Gilchrist G, Gruer L, Atkinson J. Comparison of drug use and psychiatric morbidity between prostitute and non-prostitute female drug users in Glasgow, Scotland. Addict Behav. 2005;30:1019–23.

    Article  PubMed  Google Scholar 

  6. O’Connell JM, Kerr T, Li K, et al. Requiring help injecting independently predicts incident HIV infection among injection drug users. J AIDS. 2005;40:83–8.

    Google Scholar 

  7. Krausz M, Degkwitz P, Kühne A, Verthein U. Comorbidity of opiate dependence and mental disorders. Addict Behav. 1998;23:767–84.

    Article  PubMed  CAS  Google Scholar 

  8. Torrens M, Gilchrist G, Domingo-Salvany A. Psychiatric comorbidity in illicit drug users: substance induced versus independent disorders. Drug Alcohol Depend (in press).

  9. Carey M, Carey K, Kalichman S. Risk for human immuno-deficiency virus (HIV) infection among persons with severe mental illnesses. Clin Psychol Rev. 1997;17:271–91.

    Article  PubMed  CAS  Google Scholar 

  10. Dinwiddie SH, Cottler L, Compton W, Abdallah AB. Psychopathology and HIV risk behaviors among injection drug users in and out of treatment. Drug Alcohol Depend. 1996;43:1–11.

    Article  PubMed  CAS  Google Scholar 

  11. Meade CS. Sexual risk behavior among persons dually diagnosed with severe mental illness and substance use disorder. J Subst Abuse Treat. 2006;30:147–57.

    Article  PubMed  Google Scholar 

  12. Disney E, Kidorf M, Kolodner K, et al. Psychiatric comorbidity is associated with drug use and HIV risk in syringe exchange participants. J Nerv Ment Dis. 2006;194:577–83.

    Article  PubMed  Google Scholar 

  13. Stein MD, Anderson BJ, Solomon DA, Herman DS, Ramsey SE, Brown RA. Reductions in HIV risk behaviors among depressed drug injectors. Am J Drug Alcohol Abuse. 2005;31:417–32.

    Article  PubMed  Google Scholar 

  14. Kang S, De Leon G. Correlates of drug injection behaviors among methadone outpatients. Am J Drug Alcohol Abuse. 1993;9:107–18.

    Article  Google Scholar 

  15. Mandell W, Kim J, Latkin C, Suh T. Depressive symptoms, drug network, and their synergistic effect on needle-sharing behavior among street injection drug users. Am J Drug Alcohol Abuse. 1999;25:117–27.

    Article  PubMed  CAS  Google Scholar 

  16. Morrill AC, Kasten L, Urato M, Larson MJ. Abuse, addiction, and depression as pathways to sexual risk in women and men with a history of substance abuse. J Subst Abuse. 2001;13:169–84.

    Article  PubMed  CAS  Google Scholar 

  17. Williams CT, Latkin CA. The role of depressive symptoms in predicting sex with multiple and high-risk partners. J AIDS. 2005;38:69–73.

    Google Scholar 

  18. El-Bassel N, Gilbert L, Wu E, Go H, Hill J. Relationship between drug abuse and intimate partner violence: a longitudinal study among women receiving methadone. Am J Public Health. 2005;95:465–70.

    Article  PubMed  Google Scholar 

  19. Wagner KD, Hudson SM, Latka MH, et al. The effect of intimate partner violence on receptive syringe sharing among young female injection drug users: an analysis of mediation effects. AIDS Behav. 2009;13:217–24.

    Article  PubMed  Google Scholar 

  20. Mays N, Pope C. Rigour in qualitative research. BMJ. 1995;311:109–12.

    PubMed  CAS  Google Scholar 

  21. Guest G, Bunce A, Johnson L. How many interviews are enough? An experiment with data saturation and variability. Field Methods. 2006;18:59–82.

    Article  Google Scholar 

  22. Torrens M, Serrano D, Astals M, Perez-Domınguez G, Martın-Santos R. Diagnosing psychiatric comorbidity in substance abusers validity of the Spanish versions of psychiatric research interview for substance and mental disorders (PRISM-IV) and the structured clinical interview for DSM-IV (SCID-IV). Am J Psychiatry. 2004;161:1231–7.

    Article  PubMed  Google Scholar 

  23. Hasin D, Samet S, Nunes E, Meydan J, Matseoane K, Waxman R. Diagnosis of comorbid psychiatric disorders in substance users assessed with the psychiatric research interview for substance and mental disorders for DSM-IV. Am J Psychiatry. 2006;163:689–96.

    Article  PubMed  Google Scholar 

  24. Morgello S, Holzer CE, Ryan E, et al. Interrater reliability of the psychiatric research interview for substance and mental disorders in an HIV-infected cohort: experience of the national NeuroAIDS tissue consortium. Int J Methods Psych Res. 2006;15:131–8.

    Article  CAS  Google Scholar 

  25. Hasin DS, Trautman KD, Endicott J. Psychiatric research interview for substance and mental disorders: phenomenologically based diagnosis in patients who abuse alcohol or drugs. Psychopharmacol Bull. 1998;34:3–8.

    PubMed  CAS  Google Scholar 

  26. Gutierrez-Zotes JA, Bayon C, Montserrat C, et al. Temperament and character inventory revised (TCI-R) standardization and normative data in a general population sample. Actas espanolas psiquiatria. 2004;32:8–15.

    CAS  Google Scholar 

  27. Hegarty KL, Sheehan M, Schonfeld CA. Multidimensional definition of partner abuse: development and preliminary validation of the composite abuse scale. J Fam Violence. 1999;14:399–414.

    Article  Google Scholar 

  28. Hegarty K, Bush R, Sheehan M. The composite abuse scale: further development and assessment of reliability in two clinical settings. Violence Vict. 2005;20:529–47.

    Article  PubMed  Google Scholar 

  29. Rathus SA. A 30-item schedule for assessing assertive behavior. Behav Ther. 1973;4:398–406.

    Article  Google Scholar 

  30. Norton R, Warnick B. Assertiveness as a communication construct. Hum Comm Res. 1976;3:62–6.

    Article  Google Scholar 

  31. Pearson JC. A factor analytic study of the items in the Rathus assertiveness schedule and the personal report of communication apprehension. Psychol Rep. 1979;45:491–7.

    Article  Google Scholar 

  32. Rathus SA. An experimental investigation of assertive training in a group setting. J Behav Ther Exp Psychiatry. 1972;3:81–6.

    Article  Google Scholar 

  33. Morokoff PJ, Quina K, Harlow LL, et al. Sexual assertiveness scale (SAS) for women: development and validation. J Pers Soc Psychol. 1997;73:790–804.

    Article  PubMed  CAS  Google Scholar 

  34. Darke S, Hall W, Heather N, Ward J, Wodak A. The reliability and validity of a scale to measure HIV risk-taking among intravenous drug users. AIDS. 1991;5:181–5.

    Article  PubMed  CAS  Google Scholar 

  35. SPSS Inc. Statistical Program for the Social Sciences. Chicago: SPSS; 2003.

    Google Scholar 

  36. QSR International Pty Ltd. NVivo qualitative data analysis software. Version 8; 2008.

  37. Pope C, Ziebland S, Mays N. Qualitative research in health care: analysing qualitative data. BMJ. 2000;320:114–6.

    Article  PubMed  CAS  Google Scholar 

  38. Zahari MM, Hwan Bae W, Zainal NZ, Habil H, Kamarulzaman A, Altice FL. Psychiatric and substance abuse comorbidity among HIV seropositive and HIV seronegative prisoners in Malaysia. Am J Drug Alcohol Abuse. 2010;36:31–8.

    Article  PubMed  Google Scholar 

  39. Gilchrist G, Atkinson J, Gruer L. Illicit tranquilliser use and dependence among female opiate users. Drug Alcohol Rev. 2006;25:459–61.

    Article  PubMed  Google Scholar 

  40. Gilchrist G, Gruer L, Atkinson J. Predictors of neurotic symptom severity among female drug users in Glasgow, Scotland. Drugs Educ Prev Pol. 2007;14:347–65.

    Article  Google Scholar 

  41. Brooner RK, Greenfield L, Schmidt CW, Bigelow GE. Antisocial personality disorder and HIV infection among intravenous drug abusers. Am J Psychiatry. 1993;150:53–8.

    PubMed  CAS  Google Scholar 

  42. Kelley JL, Petry NM. HIV risk behaviors in male substance abusers with and without antisocial personality disorder. J Subst Abuse Treat. 2000;19:59–66.

    Article  PubMed  CAS  Google Scholar 

  43. Ladd GT, Petry NM. Antisocial personality in treatment-seeking cocaine abusers: psychosocial functioning and HIV risk. J Subst Abuse Treat. 2003;24:323–30.

    Article  PubMed  Google Scholar 

  44. Petry NM. Discounting of delayed rewards in substance abusers: relationship to antisocial personality disorder. Psychopharmacol. 2002;162:425–32.

    Article  CAS  Google Scholar 

  45. Fassino S, Dagaa GA, Delsedimea N, Rognaa L, Boggio S. Quality of life and personality disorders in heroin abusers. Drug Alcohol Depend. 2004;76:73–80.

    Article  PubMed  CAS  Google Scholar 

  46. Hearn KD, O’Sullivan LF, El-Bassel N, Gilbert L. Intimate partner violence and monogamy among women in methadone treatment. AIDS Behav. 2005;9:177–86.

    Article  PubMed  Google Scholar 

  47. Montgomery SB, Hyde J, De Rosa CJ, et al. Gender differences in HIV risk behaviors among young injectors and their social network members. Am J Drug Alcohol Abuse. 2002;28:453–75.

    Article  PubMed  Google Scholar 

  48. Spittal PM, Craib KJP, Wood E, et al. Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver. CMAJ. 2002;166:894–9.

    PubMed  Google Scholar 

  49. MacRae R, Aalto E. Gendered power dynamics and HIV risk in drug-using sexual relationships. AIDS Care. 2000;12:505–15.

    Article  PubMed  CAS  Google Scholar 

  50. Panchanadeswaran S, Frye V, Nandi V, Galea S, Vlahov D, Ompad D. Intimate partner violence and consistent condom use among drug-using heterosexual women in New York City. Women Health. 2010;50:107–24.

    Article  PubMed  Google Scholar 

  51. Mateu-Gelabert P, Treloar C, Agulló Calatayud V, et al. How can hepatitis C be prevented in the long term? Int J Drug Policy. 2007;18:338–40.

    Article  PubMed  Google Scholar 

  52. El Bassel N, Gilbert L, Wu E, Chang M, Fontdevila J. Perpetration of intimate partner violence among men in methadone treatment programs in New York City. Am J Public Health. 2007;97:1230–2.

    Article  PubMed  Google Scholar 

  53. Copenhaver MM, Johnson BT, Lee IC, Harman JJ, Carey MP, SHARP Research Team. Behavioral HIV risk reduction among people who inject drugs: meta-analytic evidence of efficacy. J Sub Abuse Treat. 2006;31:163–71.

    Article  Google Scholar 

  54. Hien DA, Campbell AN, Killeen T, et al. The impact of trauma-focused group therapy upon HIV sexual risk behaviors in the NIDA clinical trials network “Women and trauma” multi-site study. AIDS Behav. 2010;14:421–30.

    Article  PubMed  Google Scholar 

  55. Gilbert L, El-Bassel N, Terlikbayeva A, et al. Couple-based HIV prevention for injecting drug users in Kazakhstan: a pilot intervention study. J Prev Interv Community. 2010;38:162–76.

    Article  PubMed  Google Scholar 

  56. El-Bassel N, Terlikbaeva A, Pinkham S. HIV and women who use drugs: double neglect, double risk. Lancet. 2010;376:312–3.

    Article  PubMed  Google Scholar 

  57. Rounsaville B, Kleber H. Untreated opiate addicts: how do they differ from those seeking treatment? Arch Gen Psychiatry. 1985;42:1072–7.

    PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by The Foundation for AIDS Research (amfAR) (fellowship grant #106953-43-RFAT), RD06/0001/1009 and FIS PI 07/0342. We would like to thank the staff and patients from CAS Barceloneta, CAS Extracta La Mina, CAS Sants, CAS Garbivent, Hospital del Mar Inpatient Detoxification Unit, Hospital Universitari Germans Trias i Pujol Inpatient Detoxification Unit, Dual Diagnosis Unit Centre Forum-Hospital del Mar and Juanse Hernández from the HIV treatments working group for their participation in the study. We are especially grateful to Joan Mestre, Francina Fonseca, Laura Diaz, Diana Martinez and Clara Perez for assisting with data collection.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gail Gilchrist.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gilchrist, G., Blazquez, A. & Torrens, M. Psychiatric, Behavioural and Social Risk Factors for HIV Infection Among Female Drug Users. AIDS Behav 15, 1834–1843 (2011). https://doi.org/10.1007/s10461-011-9991-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10461-011-9991-1

Keywords

Navigation